Navigation Links
HIV Vaccine Funding: 'Enough is Enough,' Says AHF in Baltimore Sun
Date:3/23/2008

US' Largest AIDS Group Calls for Funding Suspension After Trial Failures

WASHINGTON, March 23 /PRNewswire-USNewswire/ -- In a Baltimore Sun opinion piece today (http://www.baltimoresun.com/news/opinion/oped/bal- op.aidsvaccine23mar23,0,3426636.story), AIDS Healthcare Foundation (AHF) called for the suspension of costly HIV vaccine research funding and the re- allocation of resources into effective, proven HIV/AIDS prevention, testing and treatment strategies.

Co-authored by Dr. Homayoon Khanlou, AHF's Chief of Medicine/U.S. and Michael Weinstein, AHF's President, the op ed, "Enough is Enough," has been published on the eve of the HIV Vaccine Summit assembled by the director of the National Institute of Allergy and Infectious Diseases (NIAID) Dr. Anthony Fauci and scheduled for this upcoming Tuesday, March 25th in Bethesda, Maryland. This meeting of top leaders in the field is being convened at the urging of members of the scientific community concerned by the overall HIV vaccine funding strategy in the wake of a string of recent, highly publicized trial failures. The text of AHF's opinion editorial is below:

Enough is Enough

Instead of continuing to squander hundreds of millions of dollars on a futile quest for an HIV vaccine, focus AIDS spending on prevention, testing and treatment

By Homayoon Khanlou and Michael Weinstein

To control AIDS, funding must be invested in strategies that work: effective prevention efforts, routine testing and universal access to treatment - and not spent on expensive vaccine research that over 20 years has yielded little of promise other than discovering how not to make an AIDS vaccine.

The latest round of vaccine trial failures (including a large-scale Merck trial halted when the vaccine turned out to have possibly increased subjects' risk of acquiring HIV) has added to a growing consensus in the scientifi
'/>"/>

SOURCE AIDS Healthcare Foundation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. NIAID to convene HIV Vaccine Summit
2. Study Finds Single Dose of Iomai Patch With Pandemic Flu Vaccine Achieves Protective Levels
3. UNC, Harvard develop inhaled TB vaccine
4. U.S. Health Officials Back Off Preference for New MMRV Vaccine
5. Inhaled tuberculosis vaccine more effective than traditional shot
6. HPV vaccine reduces abnormal pap test results
7. NAA Calls for Immediate Recall of All Mercury-Containing Vaccines
8. Human, animal vaccine development goal of hepatitis E virus research
9. Vaccine Could One Day Control High Blood Pressure
10. United Mitochondrial Disease Foundation Statement on Vaccines, Autism and Mitochondrial Disease
11. IAVI and VaxDesign partner to develop a clinical trial in a test tube for AIDS vaccines
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 2Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 3Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 4Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 5Health News:New approach to sickle-cell disease shows promise in mice 2Health News:Antidepressants May Change Your Personality 2Health News:Antidepressants May Change Your Personality 3Health News:Antidepressants May Change Your Personality 4Health News:The Dignity Memorial(R) Network Honors Four Individuals Who Gave the Gift of Life Through Organ and Tissue Donation 2Health News:The Dignity Memorial(R) Network Honors Four Individuals Who Gave the Gift of Life Through Organ and Tissue Donation 3Health News:Workforce Alliance Earns Grant to Train Health Care Workers 2Health News:Workforce Alliance Earns Grant to Train Health Care Workers 3
Breaking Medicine Technology:FDA Makes Interim Recommendations to Address Concern of Excess Radiation Exposure during CT Perfusion Imaging 2FDA Makes Interim Recommendations to Address Concern of Excess Radiation Exposure during CT Perfusion Imaging 3Despite Limited Capital Equipment Purchases In 2009, The Global Powered Surgical Instrument Market Held Its Value At $800 Million 2Despite Limited Capital Equipment Purchases In 2009, The Global Powered Surgical Instrument Market Held Its Value At $800 Million 3CareFusion Announces Six New Pyxis(R) Technologies at the ASHP Midyear Clinical Meeting and Exhibition 2CareFusion Announces Six New Pyxis(R) Technologies at the ASHP Midyear Clinical Meeting and Exhibition 3Hospital infections cost 241 billion in lost bed days 56007 1Hospital infections cost 241 billion in lost bed days 56007 2Hill Rom and Radianse Announce Partnering Agreement to Integrate Location Sensing Technology into NaviCare 28R 29 Nurse Call 56004 1Hill Rom and Radianse Announce Partnering Agreement to Integrate Location Sensing Technology into NaviCare 28R 29 Nurse Call 56004 2Hill Rom and Radianse Announce Partnering Agreement to Integrate Location Sensing Technology into NaviCare 28R 29 Nurse Call 56004 3Hill Rom and Radianse Announce Partnering Agreement to Integrate Location Sensing Technology into NaviCare 28R 29 Nurse Call 56004 4BioMarin to Present at the Baird Healthcare Conference 13799 1BioMarin to Present at the Baird Healthcare Conference 13799 2
Other Medicine Technology:Bayer HealthCare Celebrates 20th Anniversary of Kogenate(R) Product Line and 8 Billion IU Milestone at 2008 WFH World Congress 2Bayer HealthCare Celebrates 20th Anniversary of Kogenate(R) Product Line and 8 Billion IU Milestone at 2008 WFH World Congress 3Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer 2Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer 3Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer 4Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer 5Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer 6Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer 7Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer 8Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer 9